DMS-3008

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDMS-3008
Drug Alias Nameanti-EGFR/VEGF antibody (Domantis)DMS-3008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonistsVascular endothelial growth factor receptor antagonists
TargetsEpidermal growth factor receptor erbB1Vascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDomantis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomantis Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A